Aurora Cannabis Stock Quarterly Report – Marijuana Cannabis Investing

The 1 Stock For A Estimated $50 Billion Marijuana Market

Here are just a few things People are saying about the capacity of the bud industry from that point forward, now that legalization is spreading throughout North America.

“There Hasn’t been anything like this — and given it wasn’t legislated — but you also consider the dot-com flurry. It has that kind of feel to it.” {
–Mark Whitmore, Vice Chair & Managing Partner of Deloitte

“From 2020 the legal cannabis market will create more than a quarter of a million projects. This is more than the expected jobs from utilities, manufacturing or even government projects ”
–Forbes

“You Won’t find another multibillion-dollar market growing at a 25% compound annual growth rate anywhere in the world.  That is a part of what gets the cannabis industry such a exceptional opportunity for entrepreneurs and investors.”
–Troy Dayton, CEO of Arcview Market Research

Now there is a software that will make investing in this market easier than ever!  Weed Millionaire Pro!

But look, you do not need only to speculate about trends.  Because you want to know how you can put money into and try to position yourself to profit from the upcoming revolution before the masses figure out what they’re missing.

cannabis investment

Many investors are going Treat the weed market such as a roulette wheel… plunking their hard-won money on random pot stocks they found on some penny dealer marijuana website and just hoping to strike it rich…
With no clue that they are Really in line to lose everything… or even that there is a much superior way to play the game.
However a small handful of in-the-know Investors WILL likely become filthy rich from being on the ground floor of this era of legalized marijuana.

They will be the ones who’re Investing based on solid principles and proven approaches… like the ones we have here in Weed Millionaire.
Now you see why we’re so Excited about the potential for a cannabis boom.
Since You’ve seen why we Believe there’s overwhelming evidence indicating this industry could be poised to completely explode — in fact, it’s already begun its journey that estimated $50 BILLION worth.
A little-known Canadian firm just unlocked exactly what some specialists Think could be the key to profiting off the forthcoming green revolution.
{And make no mistake — it is coming. To The tune of an estimated $80 billion!

weed stocks

Legalization is crossing over North America — 10 states plus Washington, D.C., have already voted to legalize — and full legalization came to Canada in October 2018.

The industry is worth $50 billion to the U.S. today. And since Experts have projected the U.S. industry to skyrocket to $80 billion by 2030, it’s time for investors to start paying attention.

No matter where you stand on the legalization debate, you can’t Deny the monumental investing opportunity that a possibly $80 billionbusiness represents.

However, it’s also a rather new business.
And while we at Weed Millionaire love being on the cutting edge Edge of new investing tendencies, we have been silent on this growing sector for a while.

Until now. Since a game-changing deal simply went down Between the Ontario government and a powerhouse Canadian firm. And that firm — which currently has the Chance to Rake in profits from the $7 billion Canadian legalization industry AND possibly the $80 billion US industry.
Since we have actually recommended this inventory before… for Completely different reasons.

weed stock rising

This National powerhouse has locked in key partnerships with {Behemoths such as Facebook, Amazon, and the Ontario government.  And even with that, the Organization’s CEO announced that he believes They are only 2-3% into what this business could We think you need in your portfolio for the coming green revolution.

get started weed investing

Legality of cannabis

The legality of cannabis for medical and recreational use varies by country, in terms of its possession, distribution, and cultivation, and (in regards to medical) how it can be consumed and what medical conditions it can be used for. These policies in most countries are regulated by the United Nations Single Convention on Narcotic Drugs that was ratified in 1961, along with the 1971 Convention on Psychotropic Substances and the 1988 Convention against Illicit Traffic in Narcotic Drugs and Psychotropic Substances.[1][2]

The use of cannabis for recreational purposes is prohibited in most countries; however, many have adopted a policy of decriminalization to make simple possession a non-criminal offense (often similar to a minor traffic violation). Others have much more severe penalties such as some Asian and Middle Eastern countries where possession of even small amounts is punished by imprisonment for several years.[3]

Uruguay and Canada are the only sovereign states that have fully legalized the consumption and sale of recreational cannabis nationwide. In the United States, eleven states and the District of Columbia have legalized the recreational use of cannabis although it remains federally illegal. Laws vary from state to state when it comes to the commercial sale. Court rulings in Georgia and South Africa have led to the legalization of cannabis consumption, but not legal sales. A policy of limited enforcement has also been adopted in many countries, in particular Spain and the Netherlands where the sale of cannabis is tolerated at licensed establishments.[4][5]

Video: Weed investing

Marijuana Stocks That Pay Dividends Marijuana Stocks That Pay Dividends

Best Marijuana Stocks to Watch

Aurora Cannabis Stock Quarterly Report Growing the Grow

International spending on legal cannabis is anticipated to grow 230 percent, to $31.3% billion in 2022, compared to $9.5 billion in 2017, according to Arcview Market Research and BDS Analytics. The study indicates that the majority of that, almost $23.4 billion, will be invested in the U.S. With more states voting to the legalization of marijuana and business interest tripping, that surely is reasonable.

In the year ending Jan. 11, 2019, the United States Marijuana Index dropped 20.7%, compared to a reduction of roughly 6.5% by the S&P 500. However, the bud index afterward climbed from $91 at the onset of the year to $120 May 10, 2019, an increase of approximately 13 percent, a bit better than the S&P’s rise of a bit under 12 percent.

That’s not exactly an apple-to-apple contrast, but it will make a situation to carefully explore investments in marijuana stocks before you buy.

KEY TAKEAWAYS – Aurora Cannabis Stock Quarterly Report

“Plant touching” companies take part with the actual production and supply of marijuana.
Pharma/biotech businesses are working to make medicines based on cannabinoids.
Ancillary businesses provide equipment and supplies to marijuana manufacturers.
Services companies give real estate, consulting services, technology, and more to the expanding bud business.

Aurora Cannabis Stock Quarterly Report Marijuana Regulation: The Facts

While Canada legalized marijuana in late 2018, it remains illegal under federal U.S. law and is still classified as a controlled substance with no proven medical benefit, together with heroin and LSD. However, with some 30 nations voting to make cannabis legal for medicinal use, recreational use, or both, marijuana regulation in the U.S. essentially is a hot mess.

30 – The amount of countries where voters have approved the legalization of marijuana for recreational or medical use or both.
In 2018 alone, the following states voted in favor of marijuana legalization:
Michigan: Voters legalized marijuana use and cultivation for people over age 21 and authorized the commercial sale of marijuana through state-licensed retailers.
Missouri: Voters approved legalizing marijuana for medical purposes and enabling patients to cultivate plants at home.

Aurora Cannabis Stock Quarterly Report Oklahoma: Voters approved legalizing marijuana for medical use.

Utah: Voters approved some use of marijuana for medical purposes.
How messy is it getting? The Transportation Safety Administration posted a protracted Instagram message May 2019. The TSA educated travelers that they definitely are not searching for marijuana in anyone’s luggage. But should they find it they are not able to report that fact to the national government.
The nation of regulation and federal law enforcement will, needless to state, decide the fate of this business.
Where Marijuana Stocks Have Been Recorded
The New York Stock Exchange (NYSE) and the Nasdaq acquired their first pure cannabis company listings in 2018. The Cronos Group became the first to create its trading debut on Nasdaq in February of that year, while Canopy Growth Corp. became NYSE’s very first pot set in May.
Many marijuana businesses remain penny stocks and are traded primarily in the Over-the-Counter (OTC) markets. That raises both buyer skepticism and hazard perception for any investment.
In light of the regulatory uncertainty, some businesses in the industry have led north of the border. California-based MedMen is a good example, as mentioned by CNBC.

Things to Watch Out For – Aurora Cannabis Stock Quarterly Report

Just like any investment, investors have to do their homework before they put their bets. This can be challenging for companies trading in the OTC markets, that have less stringent filing and disclosure requirements.
“Just because a cannabis company is trading on the OTC Markets Group, that does not mean they’re a sketchy stock. It merely suggests that it is the only place which they may go. So there are some good names in the OTC Markets group. Don’t let this frighten you away. And having said that, there are a number of less-than-stellar titles in the New York Stock Exchange trading there,” Debra Borchardt, co-founder, and editor-in-chief of Green Market Report stated in an Investopedia Webinar on Cannabis Investing.

Take, by way of example, INSYS Therapeutics (INSY), a Nasdaq-listed pharmaceutical company that was betting big on a cannabinoid oil-based drug to treat loss of appetite in AIDS patients and nausea brought on by chemotherapy and anti-cancer medication. The business got FDA approval for the drug Syndros at 2016. But, its stock took a beating against the 2015 highs of approximately $44 to about $5.74 in October 2017 when business executives had been charged with offering kickbacks to doctors to prescribe its fentanyl-based medication Subsys. {It closed at $3.58 on May 10, 2019.

Borchardt also cites The Green Organic Dutchman Holdings Ltd. (TGODF), a Canadian company that listed on the Toronto Stock Exchange in May 2018 and watched its shares fall 36.7% by the end of 2018. A significant reason may have been the company had no revenue. It has since reported earnings of $1.8 million to 2018.

Cultivation/Operation Investing – Aurora Cannabis Stock Quarterly Report

You can invest in the growers, the so-called”plant-touching” businesses. If you would like, you could invest in a business that’s strictly in the company of medical marijuana. {
Canopy Growth Corp. (CGC)

The very first Canadian marijuana firm, Canopy Growth Corp. is the world’s biggest publicly-traded weed company. The business owns and operates many manufacturers, producing and marketing both recreational and medical breeds. Tweed is among the organization’s most well-known brands, as a result of an association with rapper Snoop Dogg. For its 2019 fiscal year, it reported revenue of CAD 77.9 million or nearly $60 million.

In October 2017, Constellation Brands, the drink giant, and maker of Corona beer purchased a 9.9% stake in Canopy Growth. The deal provides both businesses a chance at new product lines such as cannabis-infused beverages. {
Aurora Cannabis Inc. (ACB)

Another big Canadian pot company, Aurora Cannabis became bigger in March by acquiring rival MedReleaf at a $250 million all-stock deal that was touted as the world’s largest marijuana deal thus far. Consolidating operations can help the new thing cut costs and gain efficiency. According to a press release, Aurora and MedReleaf together expect to produce over 570,000 kilograms annually of cannabis through nine centers in Canada and two in Denmark.
Aurora debuted on the Canadian enterprise stock exchange (TSX) in October 2016 and trades in the U.S. on the NYSE.
Cronos Group Inc. (CRON)

Nasdaq’s very first pot stock, Cronos Group is a Toronto-based cultivator of medical marijuana. Along with Canada, Cronos serves global markets, shipping its products to Germany, building a facility in Israel, also beginning a joint venture in Australia. Cronos Group does not have a presence in the U.S. due to the uncertainty in regulations.
Due to its 2018 fiscal year, the company generated $7.3 million in earnings.
Since the legal barriers fall, conventional vice companies like big alcohol and tobacco can be expected to get in the marijuana industry. {
Terra Tech Corp (TRTC), Aurora Cannabis Stock Quarterly Report/

Incorporated almost a decade back, Terra Tech is a diversified agricultural company with operations at the production and dispensing of medical marijuana. Its medical marijuana brand is IVXX, while its own cultivation activities operate under the brand name Edible Gardens. The business also operates retail medical marijuana shops under the title Blum.
The OTC-listed company has operations in the U.S., including a California Temporary Authorization to cultivate, manufacture, distribute, and retail cannabis. It also has Blum dispensaries and two big farming centers in Nevada.
In its latest earnings report, the business declared revenues of $8.6 million for its quarter ending March 31, 2018.

Aurora Cannabis Stock Quarterly Report Pharma/Biotech Investments

Investments will also be accessible companies that synthesize the plant to be used in various medical programs {
AbbVie (ABBV)

AbbVie is a pharmaceutical company with a synthetic cannabis-based drug on the market. The FDA approved Marinol, which will help alleviate nausea in chemotherapy patients and hunger loss in AIDS patients.
Marinol is not AbbVie’s flagship medication. Actually, it is not even the company’s biggest seller. That makes investing in this business a means to play the bud fashion without going all in. {
GW Pharmaceuticals (GWPH)

A large win for U.K.-based GW Pharmaceuticals arrived on June 25, 2018, when the FDA approved the first drug derived from an energetic marijuana ingredient rather than synthetically derived cannabinoid compounds. The medication, Epidiolex, was prescribed for the treatment of seizures related to two uncommon and severe types of epilepsy, Lennox-Gastaut syndrome, along with Dravet syndrome.
The company is listed on Nasdaq as an American Depository Receipt (ADR).

Aurora Cannabis Stock Quarterly Report Cara Therapeutics (CARA)

This clinical-stage biotechnology company develops drugs for the treatment of pruritus and severe and chronic pain. Its product pipeline includes both opioid and cannabinoid drugs. However, the CB agonist CR701 which makes it eligible for this list remains in its pre-clinical trial phase and a lot rides on the outcome of the trials ahead of the stock might get a high from marijuana.
Axim Biotechnologies (OTC: AXIM)

This biotech company is focusing on 16 drugs in various phases of pre-clinical and Phase I & II clinical trials. The medications are aimed are remedies for a number of different ailments which range from dry eyes, inflammatory bowel disease, opioid addiction, and even smoking cessation.
Ancillary Business Investments

The booming marijuana industry demands the help of a vast range of other businesses in their day-to-day operations of packaging and growing.

Aurora Cannabis Stock Quarterly Report – The Scotts Miracle-Gro Company (SMG)

In 2016, Jim Hagedorn, CEO of the lawn maintenance and garden supplies company, chose to make a massive drive into cannabis through hydroponics. In a Forbes profile titled”Cannabis Capitalist,” he explained he wanted to commit a half billion dollars in hydroponics. He did not disappoint. The business later acquired hydroponic equipment manufacturer Sunlight Supply Inc. in a deal valued at $450 million.

KushCo Holdings (OTC:KSHB)

Launched in 2010, Kush Bottles supplies packaging solutions and supplies and even branding solutions to cannabis producers. The company operates across 12 centers in the U.S.. It reported 2018 revenue of $52.07 million, a major jump from the previous year’s $18.8 million. {
GrowGeneration Corp (OTC:GRWG)

This business owns and manages specialty hydroponic and organic gardening supplies stores in 17 areas across six countries. The stores sell nutrients, soil, lighting, and hydroponic supplies. The business made $29 million in 2018 and says it’s targeting $84.6 million by 2020. {
Marijuana Business Services Stocks

From real estate needs to office requirements, there are many businesses that cater to the industry. {
General Cannabis Corp (OTC:CANN)

This company provides ancillary services to producers and companies in the marijuana business, ranging from real estate, consulting, business development, and even security. The Denver-based firm even owns a specialization cannabis lifestyle apparel line below the brand

Aurora Cannabis Stock Quarterly Report, Chiefton Supply Co..

Innovative Industrial Properties Inc. (IIPR)
This really is a Real Estate Investment Trust (REIT) dedicated to purchasing and leasing industrial properties for medical marijuana creation. It owns properties in Arizona, California, New York, Maryland, Minnesota, and Pennsylvania. Its 2018 earnings was $14.79. {
mCig Inc. (MCIG)

This diversified holding company has a portfolio that spans technology and consulting, products such as vaporizers, media assets, growers and cultivators, as well as dispensaries.

Riding Cannabis Sin Stocks, Aurora Cannabis Stock Quarterly Report

With pot’s growing popularity and the legal hurdles falling, traditional vice companies like big alcohol and tobacco started to worry about its effects on their sales.
Moody’s issued a report that suggested that tobacco and alcohol sales could have problems with growing pot sales but also identified the trend as a possible chance for these companies to create new product lines.

“As marijuana is legalized, it could substitute alcoholic beverages on some drinking occasions, but also be used to invent fresh drinks,” the report stated. “At a time when cigarette smoking is on the decline, we hope that U.S. tobacco business will enter the U.S. marijuana market, but just if marijuana becomes legal.”

These companies have already begun to get ready for that.
Constellation Brands (STZ)

Not only did the manufacturer of Modelo beer and Svedka spend $190 million to purchase a stake at Canopy Growth, but it is working on cannabis-infused non-alcoholic beverages.
The first is expected to hit stores in 2019.

Heineken N.V. (HEINY): Market Cap $50.6B

The European beverage giant’s latest offering in the pot-infused merchandise marketplace is the Lagunitas’ IPA-inspired and THC- and CBD-infused sparkling water named Hi-Fi Hops. Heineken finished the Lagunitas acquisition in 2017 after initially taking is a 50% stake in the business.
Lagunitas has tied up with medicinal marijuana company CannaCraft to bring the THC/CBD ingredients into the product that’s being distributed originally through dispensaries in California.

Molson Coors Brewing Company (TAP): Market Cap $13.7B

Molson Coors was fairly vocal about the effect of legal pot on its company. Before this season, the organization in its SEC filing listed legal bud as a risk factor to its company stating,”though the ultimate impact is presently unknown, the development of legal cannabis in certain U.S. states and Canada may result in a change of discretionary income away from our goods or a change in consumer tastes away from beer.”

In October 2018, Molson announced a deal with cannabis firm The Hydrotherapy Corp. to create cannabis-infused drinks for the Canadian industry.
Where to Purchase Marijuana Stocks

Aurora Cannabis Stock Quarterly Report. Pot stocks can be acquired from most major brokers. Their availability may depend on if they may be traded on a major market or are over-the-counter stocks. If you’ve got an interest in resources similar to this, you’ll want a brokerage account to purchase them. You may check out Investopedia’s list of the best online brokers to get you started.

error: Content is protected !!